Severe OSA Study (SOS)
A Prospective, Multi-Center, Single-Arm, Open-Label, Observational Study on the Safety and Effectiveness of the ProSomnus EVO Sleep and Snore Device in the Treatment of Severe Obstructive Sleep Apnea
Sponsor: ProSomnus Sleep Technologies
Terminated
Study terminated by Sponsor.
Other Obstructive Sleep Apnea trials with similar outcome
Listed as NCT05445869, this NA trial focuses on Obstructive Sleep Apnea and Sleep Apnea and remains terminated or withdrawn. Sponsored by ProSomnus Sleep Technologies, it has been updated 9 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
May 2024 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Oct 2023 — May 2024 [monthly]
Recruiting NA
-
Jun 2023 — Oct 2023 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
May 2023 — Jun 2023 [monthly]
Recruiting NA
-
Mar 2023 — May 2023 [monthly]
Recruiting NA
-
Jan 2023 — Mar 2023 [monthly]
Recruiting NA
-
Sep 2022 — Jan 2023 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- ProSomnus Sleep Technologies
For direct contact, visit the study record on ClinicalTrials.gov .